• Explore /
  • Poster
  • / Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: A multicenter, randomized, parallel-controlled, phase II clinical trial.

Tislelizumab plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy for elderly patients with inoperable locally advanced esophageal squamous cell carcinoma: A multicenter, randomized, parallel-controlled, phase II clinical trial.

Abstract Poster

Authors

Wencheng Zhang

Wencheng Zhang

Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China

Wencheng Zhang , Ke Zhang , Qifeng Wang , Jianzhong Cao , Chengcheng Fan , Wenbin Shen , Qin Xiao , Xiaolin Ge , Xiao Liu , Tian Zhang , Xi Chen , Jie Dong , Zewei Li , Zhunhao Zheng , Cihui Yan , Qingsong Pang , Ping Wang

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer - Local-Regional Disease

Clinical Trial Registration Number

NCT06061146

Citation

J Clin Oncol 42, 2024 (suppl 16; abstr TPS4183)

DOI

10.1200/JCO.2024.42.16_suppl.TPS4183

Abstract #

TPS4183

Poster Bd #

161b

Abstract Disclosures

Similar Posters

First Author: Jian-Ming Xu

First Author: Chen Zhang

First Author: Peng Jin

First Author: Arndt Vogel